Aditxt, Inc. (ADTX) : 4-year performance

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. 

The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 47
• Founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna in 2017 
• Headquartered in Richmond, Virginia
• https://www.aditxt.com/

IPO: June 30, 2020

Ticker: ADTX